Childhood-Onset Myasthenia Gravis, a Troublesome Clinical Entity with Heterogeneity in China
Received Date:Jaunary 03, 2018; Published Date: January 11, 2019
Myasthenia gravis (MG) is a well-known autoimmune disease involving neuromuscular transmission leading to fluctuating muscle weakness and fatigability. With the advent of immunotherapy, majority of MG sufferers will have a good outcome. However, the childhood onset MG (CMG) in China is quite different from that reported in the Western countries in light of onset age distribution, clinical types, responsiveness to immunotherapy and the long-term outcome. The mini-review focuses on the differences of Chinese CMG patients from European cases.
Keywords: myasthenia gravis; Child; Juvenile; Heterogeneity; Chinese; Dug-resistance